TABLE 2.

HIV-1 protease sequences amplified from plasma in children with <50 copies of HIV-1 RNA/ml on protease-inhibitor-containing HAART regimens^c

^aTime points with asterisks indicate previously published sequences from the same patient included to provide a complete picture of the evolutionary features of HIV-1 in plasma during HAART.

^bMay represent preexisting polymorphism or early drug resistance to nelfinavir.

^cGroup 1A, late-treated (long-term suppression) group; group 1B, late-treated (short-term suppression) group; group 2, early-treated group.